Back
64
Also listed as
NONOF
OTC
Day Range
$36.23
$37.39
52-Week Range
$35.85
$81.44
Volume
14,349,649
50D / 200D Avg
$48.31
/
$54.90
Prev Close
$36.89
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 1.6 | 0.3 |
| P/B | 0.8 | 3.0 |
| ROE % | 58.4 | 3.7 |
| Net Margin % | 33.1 | 3.8 |
| Rev Growth 5Y % | 20.5 | 10.0 |
| D/E | 0.7 | 0.2 |
Analyst Price Target
Hold
$47.00
+29.3%
Low: $42.00
High: $54.00
Forward P/E
1.75
Forward EPS
$20.82
EPS Growth (est.)
+0.0%
Est. Revenue
286.63B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$28.01
$25.65 – $31.35
|
364.42B | 5 |
| FY2029 |
$25.76
$23.59 – $28.84
|
340.73B | 2 |
| FY2028 |
$23.26
$21.30 – $26.03
|
320.97B | 5 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-04 | $5.87 | $1.00 | -83.0% |
| 2025-11-05 | $0.77 | $1.02 | +32.5% |
| 2025-08-06 | $0.93 | $0.97 | +4.3% |
| 2025-05-07 | $0.92 | $0.92 | 0.0% |
| 2025-02-05 | $0.88 | $0.91 | +3.4% |
| 2024-11-06 | $0.87 | $0.88 | +1.4% |
| 2024-08-07 | $0.70 | $0.66 | -5.9% |
| 2024-05-02 | $0.74 | $0.82 | +10.5% |
Dividend History
7 yr streakYield
0.03%
Payout Ratio
0.51%
Growth (3Y)
-8.38%
Growth (5Y)
-1.10%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 30, 2026 | Apr 08, 2026 | $0.92 | 3.65% |
| Aug 18, 2025 | Aug 26, 2025 | $0.41 | 2.29% |
| Mar 31, 2025 | Apr 08, 2025 | $0.82 | 1.70% |
| Aug 16, 2024 | Aug 26, 2024 | $0.36 | 0.76% |
| Mar 22, 2024 | Apr 02, 2024 | $0.66 | 0.86% |
| Aug 18, 2023 | Aug 29, 2023 | $0.88 | 1.12% |
| Mar 24, 2023 | Apr 04, 2023 | $1.18 | 1.15% |
| Aug 12, 2022 | Aug 23, 2022 | $0.58 | 1.49% |
| Mar 25, 2022 | Apr 05, 2022 | $1.02 | 1.48% |
| Aug 16, 2021 | Aug 25, 2021 | $0.55 | 1.43% |
| Mar 26, 2021 | Apr 07, 2021 | $0.92 | 2.12% |
| Aug 14, 2020 | Aug 25, 2020 | $0.52 | 1.98% |
| Mar 27, 2020 | Apr 07, 2020 | $0.78 | 2.17% |
| Aug 16, 2019 | Aug 27, 2019 | $0.45 | 2.37% |
| Mar 22, 2019 | Apr 02, 2019 | $0.78 | 2.44% |
| Aug 17, 2018 | Aug 28, 2018 | $0.46 | 2.67% |
| Mar 23, 2018 | Apr 03, 2018 | $0.81 | 2.64% |
| Aug 17, 2017 | Aug 29, 2017 | $0.47 | 2.52% |
| Mar 23, 2017 | Apr 04, 2017 | $0.67 | 3.39% |
| Aug 11, 2016 | Aug 23, 2016 | $0.45 | 3.04% |
Key Takeaways
Revenue grew 20.53% annually over 5 years — strong growth
ROE of 58.36% indicates high profitability
Net margin of 33.14% shows strong profitability
Generating 28.99B in free cash flow
P/E of 1.64 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 18.19%
Growth
Revenue Growth (5Y)
20.53%
Revenue (1Y)2.34%
Earnings (1Y)-2.46%
FCF Growth (3Y)-35.65%
Quality
Return on Equity
58.36%
ROIC29.96%
Net Margin33.14%
Op. Margin43.69%
Safety
Debt / Equity
0.67
Current Ratio0.80
Interest Coverage19.92
Valuation
P/E Ratio
1.64
Forward P/E1.77
P/B Ratio0.83
EV/EBITDA2.05
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.34% | Revenue Growth (3Y) | 13.12% |
| Earnings Growth (1Y) | -2.46% | Earnings Growth (3Y) | 8.49% |
| Revenue Growth (5Y) | 20.53% | Earnings Growth (5Y) | 19.84% |
| Profitability | |||
| Revenue (TTM) | 297.20B | Net Income (TTM) | 98.50B |
| ROE | 58.36% | ROA | 18.14% |
| Gross Margin | 80.34% | Operating Margin | 43.69% |
| Net Margin | 33.14% | Free Cash Flow (TTM) | 28.99B |
| ROIC | 29.96% | FCF Growth (3Y) | -35.65% |
| Safety | |||
| Debt / Equity | 0.67 | Current Ratio | 0.80 |
| Interest Coverage | 19.92 | ||
| Dividends | |||
| Dividend Yield | 0.03% | Payout Ratio | 0.51% |
| Dividend Growth (3Y) | -8.38% | Dividend Growth (5Y) | -1.10% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 1.64 | Forward P/E | 1.77 |
| P/B Ratio | 0.83 | P/S Ratio | 0.54 |
| PEG Ratio | 8.49 | Forward PEG | N/A |
| EV/EBITDA | 2.05 | Fwd EV/EBITDA | 1.78 |
| Forward P/S | 0.56 | Fwd Earnings Yield | 56.50% |
| FCF Yield | 17.95% | ||
| Market Cap | 161.50B | Enterprise Value | 265.99B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 297.20B | 290.40B | 232.26B | 176.95B | 140.80B |
| Net Income | 98.50B | 100.99B | 83.68B | 55.53B | 47.76B |
| EPS (Diluted) | 23.03 | 22.63 | 18.62 | 12.22 | 10.37 |
| Gross Profit | 238.77B | 245.88B | 196.50B | 148.51B | 117.14B |
| Operating Income | 129.83B | 128.34B | 102.57B | 74.81B | 58.64B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 542.90B | 465.80B | 314.49B | 241.26B | 194.51B |
| Total Liabilities | 348.86B | 322.31B | 207.93B | 157.77B | 123.76B |
| Shareholders' Equity | 194.05B | 143.49B | 106.56B | 83.49B | 70.75B |
| Total Debt | 130.96B | 102.79B | 27.01B | 25.78B | 26.65B |
| Cash & Equivalents | 26.46B | 15.66B | 14.39B | 12.65B | 10.72B |
| Current Assets | 172.45B | 160.90B | 139.65B | 108.19B | 85.60B |
| Current Liabilities | 215.66B | 217.53B | 169.66B | 120.94B | 99.52B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#73 of 670
Recent Activity
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026